Zydus Lifesciences on Monday acquired 6.5 per cent in Mylab Discovery Solutions from Rising Sun Holding Private Limited for Rs 106 crore, the company said in a press release. ...
Zydus Lifesciences on Friday said it has received a warning letter from USFDA relating to its injectables manufacturing facility at Jarod near Vadodara. The warning letter is an escalation ...
Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market a generic medication to treat Parkinson's disease. The company has received approval from ...
Zydus Lifesciences Ltd on Wednesday said the Mexican regulatory authority has granted marketing approval for Mamitra, a Trastuzumab biosimilar used to treat various types of cancer. Following the approval ...
Mumbai: Sigrima, Zydus Lifesciences’ biosimilar challenge to Roche’s breast cancer blockbuster brand Perjeta is swirling into controversies. After a recent injunction against its launch from the Delhi High Court ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulatory for its generic version of cancer treatment drug Cyclophosphamide capsules. The approval by ...
Zydus Lifesciences on Tuesday said it has acquired UK-based LiqMeds Group which specialises in oral liquid products for GBP 68 million (Rs 690 crores) in an all cash deal.Zydus ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic Indomethacin suppositories indicated for moderate to severe ...
New Delhi: Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a cancer treatment generic injection in the American market.The company has ...
Zydus Lifesciences Ltd on Wednesday said it has received tentative approval from the US health regulator for its generic Palbociclib tablets used to treat a certain type of breast ...